MiR-183 is a key regulator of neurite growth by suppressing the expression of mammalian target of rapamycin (mTOR) mRNA [170], and its expression levels have been shown to be significantly decreased in whole blood and PBL from ALS patients [156,157]. Here, MTOR is linked to amyotrophic lateral sclerosis.